Skip to content
‹ Back to IndustriesSciences

Addressing Educational Disparities in STEM for Underserved Youth

As the world becomes increasingly reliant on technology and innovation, careers in STEM fields have become more in demand. However, there remains a significant educational gap for underserved youth in pursuing STEM careers due to institutional biases and lack of access to resources. The efforts of two chemists, Dr. Kenneth Gibbs Jr. and Dr. Ciara…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · Community BuildingDiversityEducationInclusion
Share

Key takeaways

01

As the world becomes increasingly reliant on technology and innovation, careers in STEM fields have become more in demand.

02

However, there remains a significant educational gap for underserved youth in pursuing STEM careers due to institutional biases and lack of access to resources.

03

The efforts of two chemists, Dr.

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

As the world becomes increasingly reliant on technology and innovation, careers in STEM fields have become more in demand. However, there remains a significant educational gap for underserved youth in pursuing STEM careers due to institutional biases and lack of access to resources. The efforts of two chemists, Dr. Kenneth Gibbs Jr. and Dr. Ciara Sivels, to prepare underserved kids for jobs in STEM through their program on Challenges and Opportunities for Minorities in STEM Jobs, All-In STEM, is a step in the right direction.

All-In STEM aims to provide educational resources and mentorship opportunities for underserved youth to gain the skills and knowledge to tackle the Challenges and Opportunities for Minorities in STEM Jobs. Alex Taylor, a DEI & Belonging Researcher at the University of Sussex, highlights the need for building community and supporting each other within STEM to remind ourselves that we belong in these spaces.

Alex’s Thoughts:

“So we know that there are educational disparities within stem. That means ethnic minorities are underrepresented. And institutional bias also means that it’s more difficult for us to take up space in stem. So I think that one of the biggest challenges that we face in STEM roles is that often we’re operating within spaces.

Aren’t always welcoming and weren’t really built for us, but we’d need to foster our sense of, belonging and taking up space in these places. So I think one of the best ways that, that we can really do that is to support each other and build community with each other within stem so that we can remind ourselves that we do belong in these spaces.

And I think. On the flip side of that, because we’re not so well represented, it means that there’s a lot of opportunity to be making waves within STEM industries. I know that in psychology in particular, in research that I’m doing right now, we are underrepresented in terms of the research that’s been done, and There’s huge scope for ethnic minorities to start writing the stories of our life experiences that haven’t yet been told.

And so I would really encourage anyone who is thinking about a STEM career to follow their passion in that and find community with those of us who are in it already.”

Article written by Galya Mikova

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

Lilly breaks ground on a $5B Virginia bioconjugate plant and expects its first building to open in 2030

Lilly breaks ground on a $5B Virginia bioconjugate plant and expects its first building to open in 2030

Eli Lilly held a groundbreaking on Oct. 22 for a $5 billion manufacturing plant in Goochland County, Virginia. The company expects the first building to open in 2030. Lilly has also committed $40 million to the Virginia Center for Advanced Pharmaceutical Manufacturing, a statewide workforce development network that brings together industry, government and higher education partners. The network's plans include a pilot-scale training center in Goochland County, slated to open in 2028. That timing could let workers start training before the plant begins production.

  • 01Goochland’s pilot-scale training center is slated to open in 2028, two years before Lilly expects its first production building in 2030—signaling workforce readiness as the earliest milestone at Lilly’s first dedicated, fully integrated API and drug product facility for its bioconjugate platform and monoclonal antibody portfolio.
  • 02For anyone tracking new ADC supply, Goochland is a later story: Lilly expects to open the first building in 2030 and the second in 2031.

Nov 15, 2026

Celliaz is betting on one AAV2 vector for an eye disease with 90-plus gene causes

Celliaz is betting on one AAV2 vector for an eye disease with 90-plus gene causes

Andelyn Biosciences will develop and manufacture CLZ002, Celliaz’s investigational AAV2 gene therapy for retinitis pigmentosa, supporting IND-enabling studies and a planned Phase 1/2 trial. CLZ002 targets a retinal repair mechanism rather than specific mutations. If it works as intended, one manufacturing process could serve patients across many genetic causes of the disease.

  • 01Retinitis pigmentosa can arise from mutations in more than 90 genes; CLZ002 targets a retinal repair mechanism, and if it works as intended one AAV2 manufacturing process could serve patients that gene-specific programs would split into many products.
  • 02For a pre-IND sponsor, putting plasmid and viral vector production with one CDMO can mean fewer handoffs, and the questions worth settling early are who owns the process built on a proprietary platform and how it would move if needed.

Nov 14, 2026

Lab Manager survey finds 2027 lab hiring budgets nearly flat while supply budgets grow

Lab Manager survey finds 2027 lab hiring budgets nearly flat while supply budgets grow

Lab hiring budgets for 2027 carry a net outlook of just +2, down from +10, while consumables sit at +30 and raw materials at +31. Labs are paying for supplies and planning capital purchases further ahead. New positions face the toughest scrutiny.

  • 01Labs heading into 2027 expect their reagent budgets to grow and their headcount budgets to stall: consumables carry a net outlook of +30, hiring just +2.
  • 02Lab Manager’s read: if consumables spending stays flat, the lab is probably buying less—because respondents reported rising costs across many supply items, from reagents to shipping.
  • 03Hiring gets treated as a recurring cost, not a one-time purchase; one published example estimates ~$46,000/year for a graduate student and $80,000–$100,000 for a postdoc (with fringe) at one institution. Lab Manager recommends justifying new roles with throughput, turnaround and risk—while separating price from volume in supply-line requests.

Nov 13, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512